ImmVira’s Oncolytic Product MVR-T3011 Expanded to BCG-Naïve Bladder Cancer Patients for the First Time with Clinical Data Presented at the 2026 ASCO GU Conference
SUZHOU, China, Feb. 27, 2026 /PRNewswire/ — Intravesical BCG is the standard of care (SOC) for BCG-n...